People: Amgen Inc (AMGN.OQ)

AMGN.OQ on NASDAQ Stock Exchange Global Select Market

12:42am IST
Change (% chg)

$-3.36 (-1.39%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Gordon, Murdo 

Mr. Murdo Gordon serves as Executive Vice President of Global Commercial Operations of the Company. He will assume Hooper’s role, has been Bristol-Myers Squibb’s Chief Commercial Officer since June 2016. In this role he was responsible for commercial strategy across the globe, including all sales and marketing activities, as well as customer operations, access and pricing. Prior to his current role, Gordon served as head of worldwide markets with responsibility for the promotion of all the company’s brands globally. He moved to the U.S. in 2003 where he held senior commercial leadership positions in cardiovascular, neuroscience, oncology and immunology, as well as access and government affairs – all areas of continuing focus and importance for Amgen. Gordon joined Bristol-Myers Squibb in 1989 in Canada, after receiving a Bachelor of Science in Cell and Molecular Biology from Concordia University, Montreal. In addition, he participated in the General Management Program, CEDEP at INSEAD, Fontainebleau, France.

Basic Compensation

Total Annual Compensation, USD 1,025,670
Restricted Stock Award, USD 2,799,710
Long-Term Incentive Plans, USD --
All Other, USD 2,830,450
Fiscal Year Total, USD 6,655,840

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --